Viatris Inc. (LON:0A5V)

Market Cap	11.31B +36.5%
Revenue (ttm)	10.62B -3.0%
Net Income	-2.61B
EPS	-2.23
Shares Out	n/a
PE Ratio	n/a
Forward PE	5.27
Dividend	0.36 (2.73%)
Ex-Dividend Date	Mar 9, 2026

Volume	8,392
Average Volume	12,253
Open	13.50
Previous Close	13.36
Day's Range	13.16 - 13.39
52-Week Range	6.91 - 16.50
Beta	0.80
RSI	35.90
Earnings Date	May 8, 2026

About Viatris

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CN...

• Industry: Pharmaceutical Preparations
• Founded: 1961
• Employees: 30,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A5V

Financial Performance

In 2025, Viatris's revenue was $14.30 billion, a decrease of -2.98% compared to the previous year's $14.74 billion. Losses were -$3.51 billion, 454.2% more than in 2024.

Financial numbers in USD